Thierry Burnouf
Citado por
Citado por
Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.
A Sabchareon, T Burnouf, D Ouattara, P Attanath, H Bouharoun-Tayoun, ...
The American journal of tropical medicine and hygiene 45 (3), 297-308, 1991
Evaluation of convalescent plasma for Ebola virus disease in Guinea
J Van Griensven, T Edwards, X de Lamballerie, MG Semple, P Gallian, ...
New England Journal of Medicine 374 (1), 33-42, 2016
Fibrin sealant: scientific rationale, production methods, properties, and current clinical use
M Radosevich, HA Goubran, T Burnouf
Vox sanguinis 72 (3), 133-143, 1997
Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation?
T Burnouf, D Strunk, MBC Koh, K Schallmoser
Biomaterials 76, 371-387, 2016
Modern plasma fractionation
T Burnouf
Transfusion medicine reviews 21 (2), 101-117, 2007
In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF
CY Su, YP Kuo, YH Tseng, CH Su, T Burnouf
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2009
Blood-derived biomaterials and platelet growth factors in regenerative medicine
T Burnouf, HA Goubran, TM Chen, KL Ou, M El-Ekiaby, M Radosevic
Blood reviews 27 (2), 77-89, 2013
Nanofiltration of plasma‐derived biopharmaceutical products
T Burnouf, M Radosevich
Haemophilia 9 (1), 24-37, 2003
Reducing the risk of infection from plasma products: specific preventative strategies
T Burnouf, M Radosevich
Blood reviews 14 (2), 94-110, 2000
Regulation of tumor growth and metastasis: the role of tumor microenvironment
HA Goubran, RR Kotb, J Stakiw, ME Emara, T Burnouf
Cancer growth and metastasis 7, CGM. S11285, 2014
Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance
M Radosevich, T Burnouf
Vox sanguinis 98 (1), 12-28, 2010
Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine
T Burnouf, HA Goubran, ML Chou, D Devos, M Radosevic
Blood reviews 28 (4), 155-166, 2014
Antivenoms for the treatment of snakebite envenomings: the road ahead
JM Gutiérrez, G León, T Burnouf
Biologicals 39 (3), 129-142, 2011
The platelet–cancer loop
HA Goubran, T Burnouf, M Radosevic, M El-Ekiaby
European journal of internal medicine 24 (5), 393-400, 2013
Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion
DTB Shih, T Burnouf
New biotechnology 32 (1), 199-211, 2015
Nanofiltration, a new specific virus elimination method applied to high‐purity factor IX and factor XI concentrates
M Burnouf‐Radosevich, P Appourchaux, JJ Huart, T Burnouf
Vox sanguinis 67 (2), 132-138, 1994
Affinity chromatography in the industrial purification of plasma proteins for therapeutic use
T Burnouf, M Radosevich
Journal of biochemical and biophysical methods 49 (1-3), 575-586, 2001
Antimicrobial activity of platelet (PLT)‐poor plasma, PLT‐rich plasma, PLT gel, and solvent/detergent‐treated PLT lysate biomaterials against wound bacteria
T Burnouf, ML Chou, YW Wu, CY Su, LW Lee
Transfusion 53 (1), 138-146, 2013
Chromatography in plasma fractionation: benefits and future trends
T Burnouf
Journal of Chromatography B: Biomedical Sciences and Applications 664 (1), 3-15, 1995
Platelet–cancer interactions
HA Goubran, J Stakiw, M Radosevic, T Burnouf
Seminars in thrombosis and hemostasis 40 (03), 296-305, 2014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20